Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization

Clinical trial NCT00555594 · COMPLETED

Trial details

NCT number: NCT00555594
Sponsor: Asociación para Evitar la Ceguera en México
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Corneal Neovascularization

Start date: 2006-09-01
Primary completion: 2006-09-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.